侵袭性真菌病当前诊疗标准概述
本文概述侵袭性真菌感染诊疗标准,指出其高发病率与死亡率、高经济负担,并介绍CARE项目科学委员会为第10届CARE会议制定的科学议程,旨在回顾当前实践与推荐。
要点
- 侵袭性真菌感染危及生命,需快速诊断和优化管理以降低高发病率与死亡率。
- 过去20年多国及国际学会发布诊疗标准与指南,纳入新诊断技术和抗真菌药物。
- CARE X会议汇集多学科专家,回顾当前诊疗实践与推荐。
核心结论
- 侵袭性真菌感染需快速诊断和优化管理以降低高发病率与死亡率,且经济负担高。
- 过去20年已发布多项诊疗标准与指南,纳入新诊断技术和新抗真菌药物。
- CARE X会议旨在回顾当前诊疗实践与推荐。
研究设计与样本
- CARE项目科学委员会制定第10届CARE会议科学议程,回顾当前实践与推荐。
- 会议由吉利德欧洲有限公司组织并资助。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Invasive fungal infections are life-threatening conditions that require rapid diagnosis and optimal management to alleviate their high morbidity and mortality. They are also associated with a high economic burden, owing to prolonged hospitalization, the need for intensive supportive care, and the consumption of costly new antifungal agents. Many standards of care and guidelines have been published by national and international medical societies and organizations over the past 20 years that have embraced new diagnostic technologies and strategies, and new antifungal drugs. Recognizing the ongoing need and debate on the topic of standards for optimal diagnostics and patient care, the Scientific Committee of the Continuing Antifungal Research and Education (CARE) programme devised the scientific agenda for the 10th CARE (CARE X) meeting to review current practice and recommendations. Specialists in haematology, infectious diseases, medical microbiology and medical mycology met in Barcelona in November 2017. The meeting was organized and funded by Gilead Sciences Europe Ltd.
引用
- Richardson MD, Cuenca-Estrella M, Maertens J, et al. An introduction to current standards of CARE in invasive fungal disease. J Antimicrob Chemother. 2019. PMID: 31222309. doi:10.1093/jac/dkz036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。